Australia and US sign deal for next-generation mRNA technology

Australian biotech and Commonwealth Serology Laboratories (CSL), the world’s second-largest flu vaccine maker, have agreed to pay $312 million ($200 million) to use a US company’s breakthrough mRNA vaccine technology.

The vaccine maker announced on November 1. 2 It has licensed the new technology to Arcturus Therapeutics, a US-based mRNA drug biotechnology company.

“This collaboration is an exciting opportunity to complement CSL’s own next-generation mRNA program with a partner who has developed a platform to deliver late-stage clinical trials at scale,” CSL Chief Operating Officer Paul McKenzie said in a statement. supplies.”

“These combined capabilities will accelerate our mRNA journey.”

Arcturus’ mRNA vaccines use a “self-amplifying” technology that research shows creates copies of itself in the body, so they require far smaller doses than the multiple doses required by current mRNA vaccines.

It is now developing its own mRNA-based vaccines for COVID-19, influenza and other respiratory diseases.

Dr. Bill Mezzanotte, CSL’s chief medical officer, said the collaboration on next-generation mRNA is another example of the company’s “relentless pursuit of disruptive innovation.”

“We look forward to working closely with Arcturus to shape the future therapeutic landscape of influenza vaccines, and to leverage this exciting scientific and strategic platform to develop and commercialize vaccines against other seasonal and pandemic respiratory viruses that are in demand It hasn’t been met,” Mezzanotte, who also spent 16 years at AstraZeneca, said.

CSL was established in Australia in 1916 to meet the health needs of the country in the middle of the First World War. A century later, it has become the global leader in vaccines for rare and serious diseases, including influenza, polio and other infectious diseases.

Surgeons warn mRNA vaccines are killing men

Florida-based surgeon Joseph A. Ladapo recently warned that a COVID-19 mRNA vaccine could significantly increase the risk of dying from heart disease, especially in men.

“This analysis found an 84 percent increase in the relative incidence of heart-related death among men aged 18-39 within 28 days of mRNA vaccination,” he said.

“This is not the first study to find that mRNA COVID-19 vaccines in particular increase the risk of adverse cardiovascular outcomes.”

However, in an act of information suppression, Twitter removed some of the surgeon’s information.

At the same time, there is a growing body of data showing disinformation in different journals.

For example, a leading medical journal was recently found to have misrepresented data in a peer-reviewed study on vaccination by grouping data on people with natural immunity to COVID-19 versus those who were vaccinated.

Jessie Zhang


Jessie Zhang is a Sydney-based reporter covering Australian news, with a focus on health and the environment. Contact her at

Source link